Cure SMA is committed to supporting healthcare providers. Our educational programs aim to serve as a resource for clinicians and ensure the availability of useful, timely, and accurate information about spinal muscular atrophy (SMA).

Enduring CME Events

Mission Critical: Improving the Timeliness and Accuracy of SMA Diagnosis and Management

Credits Available:

Physicians – maximum of 0.75 AMA PRA Category 1 Credit(s)™

ABIM Diplomates – maximum of 0.75 ABIM MOC points

Estimated Time to Complete Activity: 45 minutes

Available through September 2021.

Start Activity




Post-Gene Replacement Treatment SMA Phenotypes and Multidisciplinary Care

Credits Available:

Maximum of 1.0 AMA PRA Category 1 Credit(s)™

Estimated Time to Complete Activity: 60 minutes

Available through August 2021.

Start Activity




Cure SMA Clinical Care CME Session

Credits Available:

Physicians – maximum of 3.5 AMA PRA Category 1 Credit(s)™

Pharmacists – maximum of 3.5 contact hours (.35 CEUs) of the Accreditation Council for Pharmacy Education

Nursing – maximum of 3.5 CNE contact hours. 0.2 contact hours of pharmacotherapy credit for APRNs.

Social Work – maximum of 3.5 clinical continuing education credits by the ASWBs ACE program.

Estimated Time to Complete Activity: 3 hours 30 minutes

Available through June 2021.

This content is password protected: to access, please contact [email protected].



Satellite CME SMA Symposia: Spinal Muscular Atrophy Care Management in the COVID-19 Era

Credits Available:

Physicians – maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists – maximum of 1.0 contact hours (.10 CEUs) of the Accreditation Council for Pharmacy Education

Nursing – maximum of 1.0 CNE contact hours

Social Work –  maximum of 1.0 clinical continuing education credits by the ASWBs ACE program.

Estimated Time to Complete Activity: 60 minutes

Available through June 2021.

This content is password protected: to access, please contact [email protected].



Improving Outcomes in Spinal Muscular Atrophy: Best Practices for Clinicians and Caregivers  

Credits Available:

Maximum of 1.0 AMA PRA Category 1 Credit(s)™

Estimated Time to Complete Activity: 60 minutes

Available through December 2020.

Start Activity

SMArt Moves Resource

Developmental delays can be early signs of a serious medical condition. Cure SMA created the SMArt Moves campaign to educate parents and healthcare providers about the signs of delayed milestones. With SMA, early diagnosis and early treatment is key. Visit to the SMArt Moves HubSpot for healthcare providers for additional opportunities for credit, non-credit educational activities, a provider toolkit, and more.

smartmoves hub spot


Virtual Live CME Events

While there are currently no live CME events to promote, any future events will be published here for you to register and learn more.

Non-Credit Opportunities

Cure SMA partnered with NeurologyLive and HCPLive to develop a video series entitled “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth”. The goal of this partnership is to enhance current awareness and understanding of SMA diagnostic requirements, while demonstrating opportunities to screen and evaluate suspected SMA in a remote appointment setting.

Primary Care Providers, Visit HCPLive!

Cure SMA has partnered with Platform Q to develop six modules surrounding support and care for children with SMA after gene replacement therapy. These modules showcase the family perspective on gene therapy and multidisciplinary care for SMA. Modules are available through September 2021.

Visit Neurocare Live

Cure SMA’s Virtual Summit of Strength Webinars and 2020 Virtual SMA Conference Webinars provide a variety of educational topics for SMA. These are posted on our YouTube channel and available to the public. There is no CE/CME credit associated with these videos.

Visit our YouTube Channel

In 2016, experts in SMA care met to present and discuss the latest discoveries and options for optimizing care. The meeting was organized by The University of Pennsylvania’s Penn Medicine and was co-sponsored by  Novartis Gene Therapies (formerly AveXis) and the Orphan Disease Center.

Visit our SoundCloud page